• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pulmonary complications of influenza infection: a targeted narrative review

tetano

Editor, Senior Moderator
Postgrad Med. 2019 Mar 8. doi: 10.1080/00325481.2019.1592400. [Epub ahead of print]
[h=1]Pulmonary complications of influenza infection: a targeted narrative review.[/h] Daoud A[SUP]1[/SUP], Laktineh A[SUP]1[/SUP], Macrander C[SUP]1[/SUP], Mushtaq A[SUP]1[/SUP], Soubani AO[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Severe influenza infection represents a leading cause of global morbidity and mortality. Several clinical syndromes that involve a number of organs may be associated with Influenza infection. However, lower respiratory complications remain the most common and serious sequel of influenza infection. These include influenza pneumonia, superinfection with bacteria and fungi, exacerbation of underlying lung disease and ARDS. This review analyzes the available literature on the epidemiology and clinical considerations of these conditions. It also provides an overview of the effects of type of influenza, antiviral therapy, vaccination and other therapies on the outcome of these complications.


[h=4]KEYWORDS:[/h] ARDS; complications; influenza; pulmonary

PMID: 30845866 DOI: 10.1080/00325481.2019.1592400
 
Back
Top Bottom